Skip to main content

Table 1 Univariate analysis of baseline characteristics between patients with and without rebleeding

From: The impact of albumin infusion on the risk of rebleeding and in-hospital mortality in cirrhotic patients admitted for acute gastrointestinal bleeding: a retrospective study of a single institute

 No rebleeding
(n = 1357)
Rebleeding
(n = 146)
P value
Age52.9 ± 13.054.6 ± 13.30.144
Gender (Male)907 (66.8)98 (67.1)1
Child-Pugh class  < 0.001
 A455 (33.5)19 (13.0) 
 B639 (47.1)76 (52.1) 
 C263 (19.4)51 (34.9) 
Hepatic encephalopathy94 (6.9)29 (19.9)< 0.001
Ascites699 (51.5)51 (34.9)< 0.001
Source of Bleeding
 Varices lesion1154 (85.0)121 (82.9)0.568
 Non-varices lesion96 (7.1)4 (2.7)0.068
 Lower gastrointestinal lesion43 (3.2)4 (2.7)0.974
 Unidentified lesion108 (8.0)20 (13.7)0.027
Bilirubin (umol/L) a32.5 ± 40.648.4 ± 88.4< 0.001
Albumin (g/L) a31.0 ± 6.127.8 ± 6.6< 0.001
Creatine (mol/L) a80.6 ± 60.390.1 ± 58.50.071
Hemoglobin (g/L) a75.8 ± 22.973.7 ± 22.30.274
Prothrombin time (s) a16.6 ± 9.718.3 ± 10.50.038
Balloon tamponade95 (7.0)74 (50.7)< 0.001
Endoscopic treatment489 (36.0)22 (15.1)< 0.001
Radiological intervention336 (24.8)46 (31.5)0.093
  1. avalues were obtained at admission